James L. Gulley
James L. Gulley is an American cancer researcher and the Director of the Medical Oncology Service at National Cancer Institute. Provided by Wikipedia
Showing 1 - 20 results of 23 for search 'James L. Gulley', query time: 0.04s
Refine Results
-
1
Product review: avelumab, an anti-PD-L1 antibody by Julie M. Collins, James L. Gulley
Published 2019-04-01
Article -
2
Vaccinating against cancer: getting to prime time by James L Gulley, Lawrence Fong, Ryan Chang
Published 2023-06-01
Article -
3
-
4
-
5
Celebrating a decade of the Journal for ImmunoTherapy of Cancer by James L Gulley, Pedro J Romero, Patrick Hwu, Mary Dean, Samuel Million-Weaver
Published 2022-05-01
Article -
6
Preclinical and clinical studies of a tumor targeting IL-12 immunocytokine by Christine M. Minnar, Grace Lui, James L. Gulley, Jeffrey Schlom, Sofia R. Gameiro
Published 2024-01-01
Article -
7
-
8
-
9
592 Updated recurrence free survival for neoadjuvant bintrafusp alfa (BA) for HPV unrelated HNSCC and results from BA plus a multitargeted recombinant adenovirus 5 vaccine for HPV... by Jeffrey Schlom, James L Gulley, Jennifer Marte, Elizabeth Lamping, Lisa Cordes, Seth M Steinberg, Charalampos Floudas, Jason M Redman, Clint Allen
Published 2023-11-01Article -
10
1063 Immune correlates with response in patients with metastatic solid tumors treated with a tumor targeting immunocytokine NHS-IL12 by Renee N Donahue, Jeffrey Schlom, James L Gulley, Julius Strauss, Margaret E Gatti-Mays, Nicole J Toney, Nicholas P Tschernia, Stephanie C Pitts
Published 2023-11-01Article -
11
1508 Analyzing the genomic, transcriptomic and immune landscapes associated with surface somatostatin receptor 2 (SSTR2) gene expression in nasopharyngeal carcinoma (NPC) by James L Gulley, Ari VanderWalde, Emil Lou, Nishant Gandhi, Heloisa Soares, Charalampos S Floudas, Dara Bracken-Clarke, Harris Krause, Minh Phan, Rusha Patel, Phillip Walker
Published 2023-11-01Article -
12
Assessment of Aortoiliac Atherosclerotic Plaque on CT in Prostate Cancer Patients Undergoing Treatment by Sungwon Lee, Daniel C. Elton, James L. Gulley, Perry J. Pickhardt, William L. Dahut, Ravi A. Madan, Peter A. Pinto, Deborah E. Citrin, Ronald M. Summers
Published 2022-03-01
Article -
13
1509 Characterizing somatostatin receptor 2 (SSTR2) expression and the immune landscape of olfactory neuroblastoma (ONB), sinonasal neuroendocrine carcinoma (SNEC), and sinonasal u... by James L Gulley, Ari VanderWalde, Emil Lou, Nishant Gandhi, Heloisa Soares, Charalampos S Floudas, Dara Bracken-Clarke, Harris Krause, Alex Farrell, Minh Phan, Rusha Patel, Nyall London
Published 2023-11-01Article -
14
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with targeted therapies by James L Gulley, Harriet Kluger, Hussein Tawbi, Jeffrey Sosman, Paolo A Ascierto, Michael B Atkins, Nikhil I Khushalani, Douglas B Johnson, Timonthy A Yap, Ryan J Sullivan, David Feltquate
Published 2023-03-01
Article -
15
1413 Immunogenicity of SARS-CoV-2 mRNA vaccines in individuals with thymic epithelial tumors by Arun Rajan, Renee N Donahue, Jeffrey Schlom, James L Gulley, Chen Zhao, Roa Harb, Seth M Steinberg, Eva Szabo, Shannon Swift, Meredith McAdams, Madison Ballman, Hanna S Loving, Hyoyoung Choo-Wosoba
Published 2023-11-01Article -
16
587 Nivolumab increased vaccine induced T-cell infiltration in Prostate cancer by James L Gulley, Ravi Madan, Jennifer Marte, Fatima Karzai, Amy Hankin, Houssein Abdul Sater, Manuk Manukyan, William Dahut, Shania Bailey, Wiem Lassoued, Michell Manu, Peter Pinto, Daniel Burnett, Kenneth Canubas, Nikki William
Published 2023-11-01Article -
17
1380 Non-clinical results and design of first-in-human study for GIGA-564, a third-generation anti-CTLA-4 monoclonal antibody by James L Gulley, Rong Deng, Carl Millward, Jason M Redman, Yao Chiang, Ariel Niedecken, Kacy Stadtmiller, Edward Garmey, Vincent Poon, Michael A Asensio, Janice Lansita, Kyle P Carter, Ellen K Wagner, Erica L Stone
Published 2023-11-01Article -
18
781 A phase II, open-label trial of bintrafusp alfa (M7824) in subjects with thymoma and thymic carcinoma (trial in progress) by Arun Rajan, Renee N Donahue, Jeffrey Schlom, James L Gulley, Chen Zhao, Nirmal Choradia, Seth M Steinberg, Yo-Ting Tsai, Eva Szabo, Shannon Swift, Christine Feierabend, Meredith McAdams, Carolina Celades, Molly Bingham, Susan Sansone, Meenakshi Shelat
Published 2023-11-01Article -
19
Multi-spectral immunofluorescence evaluation of the myeloid, T cell, and natural killer cell tumor immune microenvironment in chordoma may guide immunotherapeutic strategies by Diana C. Lopez, Diana C. Lopez, Yvette L. Robbins, Joshua T. Kowalczyk, Wiem Lassoued, James L. Gulley, Markku M. Miettinen, Gary L. Gallia, Gary L. Gallia, Clint T. Allen, James W. Hodge, Nyall R. London, Nyall R. London, Nyall R. London
Published 2022-10-01
Article -
20
Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer by Arun Rajan, Renee N Donahue, Jeffrey Schlom, James L Gulley, Elizabeth Lamping, Osama Rahma, Houssein Abdul Sater, Jennifer L Marté, Beatriz Walter-Rodriguez, Yulia Vugmeyster, Yo-Ting Tsai, Shania Bailey, Wiem Lassoued, Richy Agajanian, Andrew Weisman, Rena Ito, Masashi Sato, Andreas Machl
Published 2024-03-01
Article